遗传学证据支持胰岛素抵抗对循环支链氨基酸和炎症的因果作用
研究采用孟德尔随机化分析,利用53个与胰岛素抵抗相关的单核苷酸多态性,探讨胰岛素抵抗对循环血脂和代谢物的因果影响。暴露数据来自188,577名欧洲个体的荟萃全基因组关联研究,结局数据来自24,925名个体的58项核磁共振代谢指标。结果显示遗传性升高的胰岛素抵抗与所有支链氨基酸(异亮氨酸、亮氨酸、缬氨酸)及炎症标志物糖蛋白乙酰基升高相关,提示支链氨基酸代谢位于从肥胖和胰岛素抵抗到2型糖尿病的因果通路上。
要点
- 遗传性胰岛素抵抗升高与异亮氨酸、亮氨酸、缬氨酸及糖蛋白乙酰基升高相关
- 使用多种敏感性分析校正潜在遗传多效性后结果广泛一致
- 胰岛素抵抗因果性影响每种支链氨基酸和炎症,支链氨基酸代谢位于肥胖和胰岛素抵抗至2型糖尿病的因果通路
核心结论
- 提供稳健证据表明胰岛素抵抗因果性影响每种支链氨基酸和炎症,结合现有研究提示支链氨基酸代谢位于从肥胖和胰岛素抵抗到2型糖尿病的因果通路。
研究设计与样本
- 采用孟德尔随机化分析,使用近期全基因组关联研究中的53个与胰岛素抵抗相关的单核苷酸多态性。
- 暴露数据来自188,577名欧洲个体的荟萃全基因组关联研究,结局数据来自24,925名个体的全基因组关联研究,包含58项核磁共振代谢指标。
主要发现
- 遗传性升高1个标准差的胰岛素抵抗(相当于空腹胰岛素几何均值升高55%、甘油三酯升高0.89 mmol/L、高密度脂蛋白胆固醇降低0.46 mmol/L)与异亮氨酸升高0.56标准差(95%CI 0.43,0.70)相关。
- 遗传性升高1个标准差的胰岛素抵抗与亮氨酸升高0.42标准差(95%CI 0.28,0.55)相关。
- 遗传性升高1个标准差的胰岛素抵抗与缬氨酸升高0.26标准差(95%CI 0.12,0.39)相关。
- 遗传性升高1个标准差的胰岛素抵抗与糖蛋白乙酰基(炎症标志物)升高0.47标准差(95%CI 0.32,0.62)相关,每项P < 0.0003。
- 使用多种敏感性分析校正潜在遗传多效性后结果广泛一致。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Insulin resistance has deleterious effects on cardiometabolic disease. We used Mendelian randomization analyses to clarify the causal relationships of insulin resistance (IR) on circulating blood-based metabolites to shed light on potential mediators of the IR to cardiometabolic disease relationship. RESEARCH DESIGN AND METHODS: We used 53 single nucleotide polymorphisms associated with IR from a recent genome-wide association study (GWAS) to explore their effects on circulating lipids and metabolites. We used published summary-level data from two GWASs of European individuals; data on the exposure (IR) were obtained from meta-GWASs of 188,577 individuals, and data on the outcomes (58 metabolic measures assessed by nuclear magnetic resonance) were taken from a GWAS of 24,925 individuals. RESULTS: One-SD genetically elevated IR (equivalent to 55% higher geometric mean of fasting insulin, 0.89 mmol/L higher triglycerides, and 0.46 mmol/L lower HDL cholesterol) was associated with higher concentrations of all branched-chain amino acids (BCAAs)-isoleucine (0.56 SD; 95% CI 0.43, 0.70), leucine (0.42 SD; 95% CI 0.28, 0.55), and valine (0.26 SD; 95% CI 0.12, 0.39)-as well as with higher glycoprotein acetyls (an inflammation marker) (0.47 SD; 95% CI 0.32, 0.62) (P < 0.0003 for each). Results were broadly consistent when using multiple sensitivity analyses to account for potential genetic pleiotropy. CONCLUSIONS: We provide robust evidence that IR causally affects each individual BCAA and inflammation. Taken together with existing studies, this implies that BCAA metabolism lies on a causal pathway from adiposity and IR to type 2 diabetes.
引用
- Wang Q, Holmes MV, Davey Smith G, et al. Genetic Support for a Causal Role of Insulin Resistance on Circulating Branched-Chain Amino Acids and Inflammation. Diabetes Care. 2017. PMID: 29046328. doi:10.2337/dc17-1642
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。